Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Endoscopic type 3 tympanoplasty: Functional outcomes in chronic otitis media.

Bartel R, Cruellas F, Hamdan M, Benjumea F, Huguet G, Gonzalez-Compta X, Cisa E, Manos M.

Acta Otorrinolaringol Esp. 2019 Aug 2. pii: S0001-6519(19)30042-1. doi: 10.1016/j.otorri.2019.02.001. [Epub ahead of print] English, Spanish.

PMID:
31383353
2.

Transcanal endoscopic type 1 tympanoplasty in children: Cartilage butterfly and fascia temporalis graft.

Bartel R, Levorato M, Adroher M, Cardelus S, Diaz A, Lacima J, Vazquez C, Veneri A, Wienberg P, Claveria MA, Haag OH.

Int J Pediatr Otorhinolaryngol. 2019 Jun;121:120-122. doi: 10.1016/j.ijporl.2019.03.012. Epub 2019 Mar 12.

PMID:
30884342
3.

Endozoochory by mallard in New Zealand: what seeds are dispersed and how far?

Bartel RD, Sheppard JL, Lovas-Kiss Á, Green AJ.

PeerJ. 2018 May 23;6:e4811. doi: 10.7717/peerj.4811. eCollection 2018.

4.

Implementation of a unique RRT model in a tertiary care centre in Western Canada.

Tanguay T, Bartel R.

Can J Crit Care Nurs. 2017 May;28(1):34-37.

PMID:
29465178
5.

Hearing results after type III tympanoplasty: incus transposition versus PORP. A systematic review.

Bartel R, Cruellas F, Hamdan M, Gonzalez-Compta X, Cisa E, Domenech I, Manos M.

Acta Otolaryngol. 2018 Jul;138(7):617-620. doi: 10.1080/00016489.2018.1425901. Epub 2018 Jan 21. Review.

PMID:
29355069
6.

Importance of neoadjuvant chemotherapy in olfactory neuroblastoma treatment: Series report and literature review.

Bartel R, Gonzalez-Compta X, Cisa E, Cruellas F, Torres A, Rovira A, Manos M.

Acta Otorrinolaringol Esp. 2018 Jul - Aug;69(4):208-213. doi: 10.1016/j.otorri.2017.07.001. Epub 2017 Oct 20. Review. English, Spanish.

7.

Estimating Hospital-Related Deaths Due to Medical Error: A Perspective From Patient Advocates.

Kavanagh KT, Saman DM, Bartel R, Westerman K.

J Patient Saf. 2017 Mar;13(1):1-5. doi: 10.1097/PTS.0000000000000364.

PMID:
28187011
8.

Middle fossa approach: Applications in temporal bone lesions.

Domenech Juan I, Cruz Toro P, Callejo Castillo Á, Moya R, Merán Gil JL, Bartel R.

Acta Otorrinolaringol Esp. 2016 Jul-Aug;67(4):233-8. doi: 10.1016/j.otorri.2015.06.001. Epub 2015 Dec 10. English, Spanish.

9.

Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.

Ledford KJ, Murphy N, Zeigler F, Bartel RL, Tubo R.

Stem Cell Res Ther. 2015 Mar 13;6:25. doi: 10.1186/s13287-015-0007-3.

10.

Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology.

Lazure P, Bartel RC, Biller BM, Molitch ME, Rosenthal SM, Ross JL, Bernsten BD, Hayes SM.

BMC Health Serv Res. 2014 Jul 24;14:319. doi: 10.1186/1472-6963-14-319.

11.

Extreme heterogeneity in parasitism despite low population genetic structure among monarch butterflies inhabiting the Hawaiian Islands.

Pierce AA, de Roode JC, Altizer S, Bartel RA.

PLoS One. 2014 Jun 13;9(6):e100061. doi: 10.1371/journal.pone.0100061. eCollection 2014.

12.

Greater migratory propensity in hosts lowers pathogen transmission and impacts.

Hall RJ, Altizer S, Bartel RA.

J Anim Ecol. 2014 Sep;83(5):1068-77. doi: 10.1111/1365-2656.12204. Epub 2014 Mar 6.

13.

Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseases.

Ledford KJ, Murphy N, Zeigler F, Bartel RL.

Stem Cell Res Ther. 2013 Nov 1;4(6):135. doi: 10.1186/scrt346.

14.

Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages.

Ledford KJ, Zeigler F, Bartel RL.

Stem Cell Res Ther. 2013 Nov 1;4(6):134. doi: 10.1186/scrt345.

15.

From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.

Bartel RL, Booth E, Cramer C, Ledford K, Watling S, Zeigler F.

Stem Cell Rev Rep. 2013 Jun;9(3):373-83. doi: 10.1007/s12015-013-9431-x. Review.

16.

Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial.

Kaigler D, Pagni G, Park CH, Braun TM, Holman LA, Yi E, Tarle SA, Bartel RL, Giannobile WV.

Cell Transplant. 2013;22(5):767-77.

17.

The Aastrom experience.

Bartel RL, Cramer C, Ledford K, Longcore A, Parrish C, Stern T, Watling S, Zeigler F.

Stem Cell Res Ther. 2012 Jul 9;3(4):26. doi: 10.1186/scrt117. Review.

18.

Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial.

Powell RJ, Marston WA, Berceli SA, Guzman R, Henry TD, Longcore AT, Stern TP, Watling S, Bartel RL.

Mol Ther. 2012 Jun;20(6):1280-6. doi: 10.1038/mt.2012.52. Epub 2012 Mar 27.

19.

Bone repair cells for craniofacial regeneration.

Pagni G, Kaigler D, Rasperini G, Avila-Ortiz G, Bartel R, Giannobile WV.

Adv Drug Deliv Rev. 2012 Sep;64(12):1310-9. doi: 10.1016/j.addr.2012.03.005. Epub 2012 Mar 10. Review.

20.

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.

Powell RJ, Comerota AJ, Berceli SA, Guzman R, Henry TD, Tzeng E, Velazquez O, Marston WA, Bartel RL, Longcore A, Stern T, Watling S.

J Vasc Surg. 2011 Oct;54(4):1032-41. doi: 10.1016/j.jvs.2011.04.006. Epub 2011 Jul 31.

21.

Monarch butterfly migration and parasite transmission in eastern North America.

Bartel RA, Oberhauser KS, De Roode JC, Altizer SM.

Ecology. 2011 Feb;92(2):342-51.

PMID:
21618914
22.

Animal migration and infectious disease risk.

Altizer S, Bartel R, Han BA.

Science. 2011 Jan 21;331(6015):296-302. doi: 10.1126/science.1194694. Review.

PMID:
21252339
23.

Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration.

Kaigler D, Pagni G, Park CH, Tarle SA, Bartel RL, Giannobile WV.

Tissue Eng Part A. 2010 Sep;16(9):2809-20. doi: 10.1089/ten.TEA.2010.0079.

24.

Mapping oncology services in regional and rural Australia.

Underhill C, Bartel R, Goldstein D, Snodgrass H, Begbie S, Yates P, White K, Jong K, Grogan P.

Aust J Rural Health. 2009 Dec;17(6):321-9. doi: 10.1111/j.1440-1584.2009.01106.x.

PMID:
19930199
25.

Atlantic sturgeons (Acipenser sturio, Acipenser oxyrinchus): American females successful in Europe.

Tiedemann R, Moll K, Paulus KB, Scheer M, Williot P, Bartel R, Gessner J, Kirschbaum F.

Naturwissenschaften. 2007 Mar;94(3):213-7. Epub 2006 Nov 18.

PMID:
17111181
26.

Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.

Chao H, Mansfield SG, Bartel RC, Hiriyanna S, Mitchell LG, Garcia-Blanco MA, Walsh CE.

Nat Med. 2003 Aug;9(8):1015-9. Epub 2003 Jul 6.

PMID:
12847523
27.

Exacerbation of psychosis by phenylpropanolamine.

Goodhue A, Bartel RL, Smith NB.

Am J Psychiatry. 2000 Jun;157(6):1021-2. No abstract available.

PMID:
10831490
28.

Development and characterization of an in vitro gingival epithelial model.

Odioso LL, Doyle MJ, Quinn KW, Bartel RL, Zimber MP, Stevens-Burns D.

J Periodontal Res. 1995 May;30(3):210-9.

PMID:
7473005
29.

Comparison of measures used to determine substance abuse in an inpatient psychiatric population.

Albanese MJ, Bartel RL, Bruno RF, Morgenbesser MW, Schatzberg AF.

Am J Psychiatry. 1994 Jul;151(7):1077-8.

PMID:
8010367
31.

Characterization, barrier function, and drug metabolism of an in vitro skin model.

Slivka SR, Landeen LK, Zeigler F, Zimber MP, Bartel RL.

J Invest Dermatol. 1993 Jan;100(1):40-6.

32.

Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zone.

Contard P, Bartel RL, Jacobs L 2nd, Perlish JS, MacDonald ED 2nd, Handler L, Cone D, Fleischmajer R.

J Invest Dermatol. 1993 Jan;100(1):35-9.

33.

Rapid estimation of collagen in a dermal model.

Slivka SR, Bartel RL.

In Vitro Cell Dev Biol. 1992 Nov-Dec;28A(11-12):690-2. No abstract available.

PMID:
1483955
34.

Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice.

Hansbrough JF, Cooper ML, Cohen R, Spielvogel R, Greenleaf G, Bartel RL, Naughton G.

Surgery. 1992 Apr;111(4):438-46.

PMID:
1313604
35.

In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh.

Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel RL, Naughton G.

Biomaterials. 1991 Mar;12(2):243-8.

PMID:
1652296
36.

The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.

Audus KL, Bartel RL, Hidalgo IJ, Borchardt RT.

Pharm Res. 1990 May;7(5):435-51. Review.

PMID:
2195492
37.

Part II: Sex differences in persons found not guilty by reason of insanity: analysis of data from the Connecticut NGRI Registry.

Zonana HV, Bartel RL, Wells JA, Buchanan JA, Getz MA.

Bull Am Acad Psychiatry Law. 1990;18(2):129-42.

PMID:
2372574
38.

An analysis of the scholarly activities of respiratory care faculty in southern academic health centers.

Holcomb JD, Thomson WA, Bartel RE.

Respir Care. 1988 Dec;33(12):1108-13.

PMID:
10315767
39.
40.

Effect of glutamate analogues on brain tumor cell lines.

Campbell GL, Bartel R, Freidman HS, Bigner DD.

J Neurochem. 1985 Oct;45(4):1186-92.

PMID:
2863331
41.
43.

Continuous measurement of vascular diameters via television microscopy.

Devaney MJ, Rathke JE, Bartel RW, Mcdonald JE, Wiegman DL, Miller FN, Harris PD.

ISA Trans. 1976;15(1):73-8.

PMID:
950283
44.

Continuous measurement of vascular diameters via television microscopy.

Devaney MJ, Rathke JE, Bartel RW, McDonald JE, Wiegman DL, Miller FN, Harris PD.

Biomed Sci Instrum. 1975;11:1-6. No abstract available.

PMID:
1125362
45.

[Studies on some pharmacodynamic properties of hydroxyzine (atarax)].

RAICIULESCU N, BITTMAN E, BARTEL R.

Acta Physiol Acad Sci Hung. 1959;15(2):201-15. French. No abstract available.

PMID:
13660857

Supplemental Content

Loading ...
Support Center